News Daily News Apixaban Appears Safer, More Effective Than Rivaroxaban in Medicare Study By Todd Neale December 27, 2021
News Daily News Another Win for Guided P2Y12 Therapy in ACS: Meta-analysis By Yael L. Maxwell December 24, 2021
News Daily News Black Patients With Chest Pain Differ From Whites, but Risks Are Similar By Michael O'Riordan December 23, 2021
News Daily News FDA Approves Inclisiran, a Twice-Yearly Injection to Lower LDL Levels By Michael O'Riordan December 22, 2021
News Daily News Still No Edge for Bivalirudin in VALIDATE-SWEDEHEART’s STEMI Patients By Shelley Wood December 22, 2021
News Daily News Correction Issued for Controversial Study Linking COVID-19 Vaccines to ACS Risk By Todd Neale December 22, 2021
News Daily News Women Less Likely Than Men to Experience SCD During Sports By Michael O'Riordan December 21, 2021
News Daily News Studies Zero in on Delayed Conduction Problems After TAVI By Todd Neale December 21, 2021
News Daily News FDA Approves Two Additional Indications for Rivaroxaban in Children By L.A. McKeown December 21, 2021